New surgical method for treating severe brain injuries
Single stage surgical intervention for treatment of severe traumatic brain injury
This study is testing a new surgical method for people with severe traumatic brain injuries that uses a special gel to close the skull in one step instead of two, which could help them heal faster and have better results.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Colorado State University NIH-funded |
| Lab location | 1 site (Fort Collins, United States) |
| Project ID | NIH-11042241 on NIH RePORTER |
What this research studies
This research investigates a groundbreaking surgical approach for patients with severe traumatic brain injury (TBI) by using a novel hydrogel material during a single-stage decompressive craniectomy. Traditionally, patients undergo a two-step process where a cranial defect is created and later repaired, but this new method aims to eliminate the need for a second surgery. The hydrogel, made from natural materials, can be easily shaped by surgeons and solidifies quickly with UV light, allowing for immediate closure of the cranial defect. This innovative technique could significantly improve recovery times and outcomes for TBI patients.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals suffering from severe traumatic brain injuries requiring decompressive craniectomy.
Not a fit: Patients with mild brain injuries or those who do not require surgical intervention may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to faster recovery and reduced need for additional surgeries for patients with severe traumatic brain injuries.
How similar studies have performed: While the use of hydrogel materials in surgical procedures is gaining interest, this specific single-stage approach for TBI treatment is novel and has not been widely tested.
Where this research is happening
Fort Collins, United States
- Colorado State University — Fort Collins, United States (Active)
Researchers
- Principal investigator: Detamore, Michael S. — Colorado State University
- Study coordinator: Detamore, Michael S.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.